RELATIONSHIP OF UPPER AND LOWER BODY MUSCULAR STRENGTH WITH CARDIO-RESPIRATORY ENDURANCE AMONG SCHOOL GOING CHILDREN

The aim of this study was to explore the relationship between upper and lower body muscular strength as well as cardio-respiratory endurance among school going children 11 to 15 years of age. A sample of 1750 boys was drawn from the targeted population. Children were tested on handgrip (HG) to measure the strength of upper body muscles, on Standing Broad Jump (SBJ) to measure the strength of lower body muscles, used Beep Test (BT) for cardio-respiratory endurance and height and weight to determine Body Mass Index (BMI). Multiple regression analysis depicted association of lower body muscular strength (SBJ) with upper body muscular strength (HG) and cardio-respiratory endurance (BT) (R 2= 0.011 and 0.10 respectively). The analysis reflected the significant relationship, though weak, between lower body strength (SBJ) and upper body strength (HG) and cardiorespiratory endurance (BT). Hence lower body muscular strength can be considered useful indicator for muscular strength and cardio-respiratory endurance among school going children

Synergistic effects of a copper–cobalt–nitroisophthalic acid/neodymium oxide composite on the electrochemical performance of hybrid supercapacitors

Hybrid supercapacitors can produce extraordinary advances in specific power and energy to display better electrochemical performance and better cyclic stability. Amalgamating metal oxides with metal–organic frameworks endows the prepared composites with unique properties and advantageous possibilities for enhancing the electrochemical capabilities. The present study focused on the synergistic effects of the CuCo(5-NIPA)–Nd2O3 composite. Employing a half-cell configuration, we conducted a comprehensive electrochemical analysis of CuCo(5-NIPA), Nd2O3, and their composite. Owing to the best performance of the composite, the hybrid device prepared from CuCo(5-NIPA)–Nd2O3 and activated carbon demonstrated a specific capacity of 467.5 C g−1 at a scan rate of 3 mV s−1, as well as a phenomenal energy and power density of 109.68 W h kg−1 and 4507 W kg−1, respectively. Afterwards, semi-empirical techniques and models were used to investigate the capacitive and diffusive mechanisms, providing important insights into the unique properties of battery–supercapacitor hybrids. These findings highlight the enhanced performance of the CuCo(5-NIPA)–Nd2O3 composite, establishing it as a unique and intriguing candidate for applications requiring the merging of battery and supercapacitor technologies

Increasing frailty is associated with higher prevalence and reduced recognition of delirium in older hospitalised inpatients: results of a multi-centre study

Purpose: Delirium is a neuropsychiatric disorder delineated by an acute change in cognition, attention, and consciousness. It is common, particularly in older adults, but poorly recognised. Frailty is the accumulation of deficits conferring an increased risk of adverse outcomes. We set out to determine how severity of frailty, as measured using the CFS, affected delirium rates, and recognition in hospitalised older people in the United Kingdom. Methods: Adults over 65 years were included in an observational multi-centre audit across UK hospitals, two prospective rounds, and one retrospective note review. Clinical Frailty Scale (CFS), delirium status, and 30-day outcomes were recorded. Results: The overall prevalence of delirium was 16.3% (483). Patients with delirium were more frail than patients without delirium (median CFS 6 vs 4). The risk of delirium was greater with increasing frailty [OR 2.9 (1.8–4.6) in CFS 4 vs 1–3; OR 12.4 (6.2–24.5) in CFS 8 vs 1–3]. Higher CFS was associated with reduced recognition of delirium (OR of 0.7 (0.3–1.9) in CFS 4 compared to 0.2 (0.1–0.7) in CFS 8). These risks were both independent of age and dementia. Conclusion: We have demonstrated an incremental increase in risk of delirium with increasing frailty. This has important clinical implications, suggesting that frailty may provide a more nuanced measure of vulnerability to delirium and poor outcomes. However, the most frail patients are least likely to have their delirium diagnosed and there is a significant lack of research into the underlying pathophysiology of both of these common geriatric syndromes

Investigating the influence of copper benzene-1,3,5-tricarboxylate (Cu-PDC) and benzene-1,2-dicarboxylate ligands (Cu-BTC) on the electrochemical capacity of hybrid supercapacitors

The elevated energy demand and crises have rooted the urge to develop advanced electrode materials that can overcome the energy dilemma present all over the globe. Metal-organic frameworks (MOFs) have emerged as promising electrode materials in recent times due to their better electrochemical properties. Herein the metal ligand synergy produced in MOFs is observed for the same metal center (Cu) with different ligands i.e., benzene-1,3,5-tricarboxylate (1,3,5-BTC) and benzene-1,2-dicarboxylate (1,2-BDC). The hybrid device of the best performing MOF (Cu-1,3,5-BTC//AC) reveals the energy and power density of 86.32 Wh kg-1 and 680 W kg-1, respectively. Even at the highest current density of 15 A/g, the device retained the Es of 21.25 Wh kg-1 and Ps of 12,750 W kg-1. Furthermore, the semi-empirical approach was utilized for the evaluation of capacitive and diffusive contributions

Role of genetic polymorphisms in clopidogrel response variability: a systematic review

Introduction Clopidogrel is a P2Y12 inhibitor that has become a mainstay treatment following percutaneous intervention with drug-eluting stent placement to decrease restenosis and its potential complications, including sudden cardiac death and ischaemic strokes in patients with significant vascular disease.Areas covered As a prodrug, the metabolism and efficacy of clopidogrel are contingent on the presence of wild-type CYP450 (CYP2C19) alleles. Genetic polymorphisms and variants are well known to impair its ability to prevent major adverse cardiovascular events in these patients, with inadequate response rates as high as 30% in previous publications. Patterns of allelic frequencies are expected to exhibit similarities between individuals of the same ancestry, ethnic group or geographic region. Accordingly, we seek to further elucidate worldwide prevalence rates for genetic polymorphisms in the CYP2C19-dependent metabolism of clopidogrel and review the potential of personalised CYP2C19 genotyping in clinical practice to mitigate this high treatment resistance and its associated burden on patients.Experts’ commentary Our findings support the consideration of genotyping before initiation of therapy to guide adequate dosage or substitutions of other P2Y12 inhibitors to promote personalised, precision medicine and to prevent adverse events when these therapies may inevitably fail in patients with variants of the CYP450 (CYP2C19) system